Community-acquired invasive aspergillosis and outdoor filamentous fungal spore load: A relationship?

Clinical Microbiology and Infection

Volumn 17, Issue 9, 2011, Pages 1387-1390

  Brenier Pinchart, M P ^a   Lebeau, B ^a   Borel, J L ^b   Quesada, J L ^a   Mallaret, M R ^a   Garban, F ^a   Brion, J P ^a   Molina, L ^a   Bosson, J L ^a   Thiebaut Bertrand, A ^a   Grillot, R ^a   Pelloux, H ^a  

^a GRENOBLE UNIVERSITY HOSPITAL   (France)

^b UNIV GRENOBLE ALPES   (France)

Author keywords

Community acquired; Environment; Filamentous fungus; Invasive aspergillosis; Nosocomial; Prevention

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID;

ACUTE GRANULOCYTIC LEUKEMIA; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; COMMUNITY ACQUIRED INVASIVE ASPERGILLOSIS; CONTROLLED STUDY; FUNGUS SPORE; HIGH RISK PATIENT; HOSPITAL INFECTION; HOSPITAL PATIENT; HUMAN; INFECTION PREVENTION; INVASIVE ASPERGILLOSIS; MAJOR CLINICAL STUDY; MYELOMA; NONHODGKIN LYMPHOMA; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; SEASONAL VARIATION;

FUNGI;

EID: 80051885696     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/j.1469-0691.2011.03523.x     Document Type: Article

References (17)

1. Carreras E. Preventing exposure to moulds. Clin Microbiol Infect 2006; 12: 77-83.
2. Mahieu LM, De Dooy JJ, Van Laer FA et al. A prospective study on factors influencing Aspergillus spore load in the air during renovation works in a neonatal intensive care unit. J Hosp Infect 2000; 45: 191-197.
3. Alberti C, Bouakline A, Ribaud P et al. Relationship between environmental fungal contamination and the incidence of invasive aspergillosis in hematology patients. J Hosp Infect 2001; 48: 198-206.
4. Tablan OC, Anderson LJ, Besser R, Bridges C, Hajjeh R, Healthcare Infection Control Practices Advisory Committee. Centers for Disease Control and Prevention. Guidelines for preventing health-care-associated pneumonia. MMWR 2004; 53: 1-36.
5. Gangneux JP, Bretagne S, Cordonnier C et al. Prevention of nosocomial fungal infection: the French approach. Clin Infect Dis 2002; 35: 343-346.
6. Munoz P, Burillo A, Bouza E. Environmental surveillance and other control measures in the prevention of nosocomial fungal infections. Clin Microbiol Infect 2001; 7: 38-45.
7. Fourneret-Vivier A, Lebeau B, Mallaret MR et al. Hospital-wide prospective mandatory surveillance of invasive aspergillosis in a French teaching hospital (2000-2002). J Hosp Infect 2006; 62: 22-28.
8. Hajjeh RA, Warnock DW. Counterpoint: invasive aspergillosis and the environment-rethinking our approach to prevention. Clin Infect Dis 2001; 33: 1549-1552.
9. Panackal AA, Li H, Kontoyiannis DP et al. Geoclimatic influences on invasive aspergillosis after hematopoietic stem cell transplantation. Clin Infect Dis 2010; 50: 1588-1597.
10. Brenier-Pinchart MP, Lebeau B, Quesada JL et al. Influence of internal and outdoor factors on filamentous fungal flora in hematology wards. Am J Infect Control 2009; 37: 631-637.
11. Oliveira M, Ribeiro H, Abreu I. Annual variation of fungal spores in atmosphere of Porto: 2003. Ann Agric Environ Med 2005; 12: 309-315.
12. De Pauw B, Walsh TJ, Donnelly JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813-1821.
13. Gangneux JP, Bousseau A, Cornillet A, Kauffmann-Lacroix C. Control of fungal environmental risk in French hospitals. J Mycol Med 2006; 16: 204-211.
14. Nicolle MC, Benet T, Vanhems P. Aspergillosis: nosocomial or community-acquired? Med Mycol 2011; 49: 524-529.
15. Mantadakis E, Samonis G. Novel preventive strategies against invasive aspergillosis. Med Mycol 2006; 44: S327-S332.
16. Partridge-Hinckley K, Liddell GM, Almyroudis NG, Segal BH. Infection control measures to prevent invasive mould diseases in hematopoietic stem cell transplant recipients. Mycopathologia 2009; 168: 329-337.
17. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-360.